Elizabeth Weise, USA TODAY

Elizabeth Weise

USA TODAY

San Francisco, CA, United States

Contact Elizabeth

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • USA TODAY
  • The News Leader
  • North Jersey News
  • The Columbus Dispatch
Past:
  • Enquirer
  • Daily Record
  • BlueRidgeNow
  • delawareonline
  • The Spectrum
  • The Tennessean
  • argusleader
  • The Atlanta Journal-Constitution
  • Indianapolis Star
  • Rochester D and C
  • and more…

Recent articles by Elizabeth:

We're one-third of the way to a widely available coronavirus vaccine, experts say

USA TODAY created a panel of nationally known experts to estimate how far we are from when a COVID-19 vaccine will be available to all Americans. → Read More

VP Pence doesn't mention wearing masks as a way of stopping the spread of coronavirus

Vice President Mike Pence didn't mention face masks or social distancing as ways to protect against coronavirus at a White House task force briefing. → Read More

Pregnant women with COVID-19 are 5 times more likely to be hospitalized

Pregnant women may be at increased risk for severe illness from COVID-19 compared with non-pregnant women but their death rates aren't higher. → Read More

Bill Gates is not secretly plotting microchips in a coronavirus vaccine. Misinformation and conspiracy theories are dangerous for everyone.

A coronavirus vaccine is not yet here, but conspiracy theories are already swirling, potentially driving people away from a lifesaving immunization. → Read More

Russia declares state of emergency over Arctic Circle oil spill caused by melting permafrost

Melting permafrost caused a fuel tank holding 21,000 tons of diesel oil to collapse in Russia's Arctic Circle, leading to a 135-square mile oil spill. According to Rosprirodnadzor, the Federal Service for Supervision of Natural Resources, 6,000 tons spilled onto the ground, another 15,000 tons into the water. Oil products got into the Ambarnaya and Daldykan rivers and in almost all their… → Read More

A coronavirus vaccine could require you to get two shots. Here's why.

A vaccine against the coronavirus may not be as simple as one jab and you're immune. There's a high likelihood an eventual vaccine will → Read More

A coronavirus vaccine could require you to get two shots. Here's why.

There's a high likelihood a coronavirus vaccine will need two shots a month or so apart, with the possibility of a booster several years later. → Read More

US pledges up to $1.2 billion to access 300 million doses of experimental COVID-19 vaccine

The United States has pledged to pay as much as $1.2 billion to get early access to 300 million doses of an experimental COVID-19 vaccine being developed → Read More

US pledges up to $1.2 billion to access 300 million doses of experimental COVID-19 vaccine

The United States has pledged to pay as much as $1.2 billion to get early access to 300 million doses of an experimental COVID-19 vaccine being developed → Read More

US pledges up to $1.2 billion to access 300 million doses of experimental COVID-19 vaccine

An experimental COVID-19 vaccine being developed at Oxford by AstraZeneca received a big order: $1.2 billion from the United States for 300 million doses. → Read More

When a coronavirus vaccine is developed, who will be first in line to get it? A CDC panel usually decides

No matter how well-prepared we are, there won’t immediately be enough to coronavirus vaccine to immunize all Americans. Choices will have to be made. → Read More

Latest on global search for coronavirus vaccine: Oxford vaccine may protect monkeys from COVID

This week's coronavirus vaccine race news: Oxford's vaccine protects monkeys and the WHO now lists 110 possible COVID-19 vaccine candidates. → Read More

Trump announces 'Operation Warp Speed,' says U.S. could have coronavirus vaccine by January

President Trump Friday announced Operation Warp Speed, a government coordinating effort aimed at securing a coronavirus vaccine by the end of the year. → Read More

In race for coronavirus vaccine, will Operation Warp Speed focus the work or politicize it?

Operation Warp Speed is tasked with the goal of a COVID-19 vaccine by January. Despite billions invested, how it functions remains opaque, experts say. → Read More

Can I catch coronavirus again if I've had it? At least not right away. Later, who knows?

It doesn’t appear people who have had a confirmed case of COVID-19 can quickly become reinfected with the virus that causes the disease. studies show. → Read More

Many coronavirus mutations are circling the globe, but we don't know if any are more dangerous

The coronavirus is mutating as it spreads across the planet. The unanswered question is how different these strains are and if they're more dangerous. → Read More

Latest on global search for coronavirus vaccine: 1st US candidate set for Phase 2; WHO tracks 8 efforts; Pfizer tests in humans

As the all-out effort for a vaccine accelerates, USA TODAY is rounding up some of the week's most notable developments. → Read More

Study: Remdesivir appears to speed recovery times in hospitalized COVID-19 patients

Early results released from a federal study found patients who received remdesivir had a 31% faster recovery time than those who received a placebo. → Read More

In race to stop COVID-19, remdesivir shows some promise but there's still no proven treatment

Among the most-discussed potential treatments for the coronavirus are hydroxychloroquine, remdesivir and blood therapies. Here's what to know. → Read More

COVID-19 treatment: FDA says hydroxychloroquine touted by Trump is not safe or effective

The FDA on Friday cautioned against the use of hydroxychloroquine or chloroquine for COVID-19 treatment outside of hospitals or clinical trials. → Read More